This study aimed to molecularly engineer the extracellular matrix of damaged skin using novel biomimetic proteoglycans (BPGs). The objectives were to determine if BPGs increase skin compliance and evaluate their diffusion behavior in skin. Piezoelectric finger testing showed BPGs exceeded the target of reducing skin's elastic modulus by 25%, increasing compliance. Confocal microscopy imaging revealed BPGs diffused away from injection sites over 24 hours as they integrated into the existing extracellular matrix. In conclusion, BPGs demonstrated molecular engineering of porcine skin's extracellular matrix for the first time, offering potential treatment for aged, diseased skin against tearing and infection at a fraction of the cost of natural proteoglycan injections.